Galieve Cool Mint 500+267+160 mg/10 ml oral suspension Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

galieve cool mint 500+267+160 mg/10 ml oral suspension

reckitt benckiser healthcare (scandinavia) a/s - calciumcarbonat, natriumalginat, natriumhydrogencarbonat - oral suspension - 500+267+160 mg/10 ml

Galieve Cool Mint 500+267+160 mg/10 ml oral suspension i brev Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

galieve cool mint 500+267+160 mg/10 ml oral suspension i brev

reckitt benckiser healthcare (scandinavia) a/s - calciumcarbonat, natriumalginat, natriumhydrogencarbonat - oral suspension i brev - 500+267+160 mg/10 ml

Galieve Forte 500+213+325 mg/10 ml oral suspension i brev Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

galieve forte 500+213+325 mg/10 ml oral suspension i brev

reckitt benckiser a/s - calciumcarbonat, natriumalginat, natriumhydrogencarbonat - oral suspension i brev - 500+213+325 mg/10 ml

Xaluprine (previously Mercaptopurine Nova Laboratories) Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

xaluprine (previously mercaptopurine nova laboratories)

nova laboratories ireland limited - 6-mercaptopurinmonohydrat - leukæmi, lymfoid - antineoplastiske midler - xaluprine er indiceret til behandling af akut lymfoblastisk leukæmi (all) hos voksne, unge og børn.